Depression — Mental Health Pathways in Internet Support Groups
Citation(s)
Vlahovic, T , Wang, Y.-C., Kraut, R. E., & Levine, J. M. (2014). Support matching and satisfaction in an online breast cancer support community. CHI'14: Proceedings of the ACM Conference on Human Factors in Computing Systems (pp. 1625-1634 ). NY: ACM.
Wang YC, Kraut RE, Levine JM Eliciting and receiving online support: using computer-aided content analysis to examine the dynamics of online social support. J Med Internet Res. 2015 Apr 20;17(4):e99. doi: 10.2196/jmir.3558.
Wang, Y , Kraut, R., & Levine, J. (2012). To stay or leave? the relationship of emotional and informational support to commitment in online health support groups CSCW '12 Proceedings of the ACM 2012 conference on Computer Supported Cooperative Work (pp. 833-842). NY: ACM.
Yang D, Kraut R, Levine JM Commitment of Newcomers and Old-timers to Online Health Support Communities. Proc SIGCHI Conf Hum Factor Comput Syst. 2017 May;2017:6363-6375. doi: 10.1145/3025453.3026008.
Yang D, Kraut R, Smith T, Mayfield E, Jurafsky D Seekers, Providers, Welcomers, and Storytellers: Modeling Social Roles in Online Health Communities. Proc SIGCHI Conf Hum Factor Comput Syst. 2019 May;2019. pii: 344. doi: 10.1145/3290605.3300574.
Yang D, Yao Z, Kraut R Self-disclosure and Channel Difference in Online Health Support Groups. Proc Int AAAI Conf Weblogs Soc Media. 2017 May;2017:704-707.
Yang D, Yao Z, Seering J, Kraut R The Channel Matters: Self-disclosure, Reciprocity and Social Support in Online Cancer Support Groups. Proc SIGCHI Conf Hum Factor Comput Syst. 2019 May;2019. pii: 31. doi: 10.1145/3290605.3300261.
Internet Support Groups: Identifying and Improving Pathways for Mental Health
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
